Associated Papers
The clinical significance of the Mediterranean fever gene MEFV variants in Castleman disease.
Du Y et al.
Communications Medicine, 2026
Is the decision maker a key determinant of colchicine withdrawal success in paediatric heterozygous familial Mediterranean fever patients?
Özomay Baykal G et al.
Scandinavian Journal of Rheumatology, 2026
Impact of Mediterranean Fever Gene Mutations on Clinical Characteristics in Patients With Inflammatory Bowel Disease.
Nakamura T et al.
Gastro Hep Advances, 2026
Increasing Importance of Genotype-Phenotype Correlations Associated with Common and Rare MEFV Gene Mutations in FMF Patients in the Last Thirty Years.
Yildirim S et al.
Journal of Clinical Medicine, 2025
Characteristics of arthritis in patients with familial Mediterranean fever.
Yenigun S et al.
Internal Medicine Journal, 2024
Long-term renal outcome of Cryopyrin-associated periodic syndrome (CAPS) under anti-Interleukin-1 therapy.
Russwurm M et al.
Scientific Reports, 2024
The roles of SFKs in the regulation of proinflammatory cytokines and NLRP3 in familial mediterranean fever patients.
İçen Taşkın I et al.
Cytokine, 2024
Familial Mediterranean fever with colonic lesions: A case report.
Ariga H et al.
Den Open, 2024
Expanding the VEXAS diagnostic workup: the role of peripheral blood cytological analysis.
Baggio C et al.
Frontiers in Immunology, 2024
Genotype Mutations in Palestinian Children with Familial Mediterranean Fever: Clinical Profile, and Response to Colchicine Treatment: A Retrospective Cohort Study.
Shrateh ON et al.
Mediterranean Journal of Rheumatology, 2023
Clinical features, functional status, and quality of life in patients with late-onset familial Mediterranean fever.
Gursoy DE et al.
Northern Clinics of Istanbul, 2023
Anti-Inflammatory, Antioxidant, and Anti-Atherosclerotic Effects of Natural Supplements on Patients with FMF-Related AA Amyloidosis: A Non-Randomized 24-Week Open-Label Interventional Study.
Romano M et al.
Life (basel, Switzerland), 2022
Plasminogen gene polymorphisms [c.924C>T and IVS 8+14 G>A] in periodontitis and familial Mediterranean fever: A case-control study.
Fentoğlu Ö et al.
Journal of Periodontal Research, 2022
Assessment of vascular damage in children and young adults with Familial Mediterranean Fever.
Vampertzi O et al.
Rheumatology International, 2022
Frequencies of the MEFV Gene Mutations in Azerbaijan.
Huseynova LS et al.
Balkan Journal of Medical Genetics : Bjmg, 2021
Phenotypic characterization of Familial Mediterranean Fever patients harboring variants of uncertain significance
Sarı A et al.
Turkish Journal of Medical Sciences, 2021
Similarities between pediatric FMF patients with sacroiliitis and pediatric juvenile spondyloarthropathy patients with sacroiliitis: a preliminary study.
Özdel S et al.
Acta Clinica Belgica, 2021
Cardiovascular Sequelae and Genetics of Familial Mediterranean Fever: A Literature Review.
Malik J et al.
Pulse (basel, Switzerland), 2021
Evaluation of the Clinical Effects and Frequency of MEFV Gene Mutation in Patients with Inflammatory Bowel Disease.
Sahin S et al.
Gastroenterology Research and Practice, 2021
Anti-IL1 treatment in colchicine-resistant paediatric FMF patients: real life data from the HELIOS registry.
Sag E et al.
Rheumatology (oxford, England), 2020
Long term administration of tocilizumab improves renal amyloid A (AA) amyloidosis deposition in Familial Mediterranean fever.
Inui K et al.
Modern Rheumatology Case Reports, 2020
Comorbidities in familial Mediterranean fever: analysis of 2000 genetically confirmed patients.
Balcı-Peynircioğlu B et al.
Rheumatology (oxford, England), 2020
The association of MEFV gene mutations with the disease risk and severity of systemic juvenile idiopathic arthritis.
Zhong L et al.
Pediatric Rheumatology Online Journal, 2020
MEFV Gene-Related Enterocolitis Account for Some Cases Diagnosed as Inflammatory Bowel Disease Unclassified.
Saito D et al.
Digestion, 2020
Single-Center Overview of Pediatric Monogenic Autoinflammatory Diseases in the Past Decade: A Summary and Beyond.
Wang W et al.
Frontiers in Immunology, 2020
[Atypical clinical presentation of familial Mediterranean fever resembling colonic diverticulitis in an elderly patient:a case report].
Takahashi S et al.
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-enterology, 2020
MEFV gene mutations in neuro-Behçet's disease and neuro-Sweet disease.
Ishikawa H et al.
Annals of Clinical and Translational Neurology, 2019
Anti-interleukin-1 treatment among patients with familial Mediterranean fever resistant to colchicine treatment. Retrospective analysis.
Sargin G et al.
Sao Paulo Medical Journal = Revista Paulista De Medicina, 2019
Idiopathic CRMO and MEFV Gene Variant Alleles: Is There Any Relationship?
Salehzadeh F et al.
Case Reports in Rheumatology, 2019
Serum amyloid A1 (SAA1) gene polymorphisms in Japanese patients with adult-onset Still's disease.
Yashiro M et al.
Medicine, 2018
Vasculitis and vasculitis-like manifestations in monogenic autoinflammatory syndromes.
Jain A et al.
Rheumatology International, 2018
One novel and two uncommon MEFV mutations in Japanese patients with familial Mediterranean fever: a clinicogenetic study.
Kishida D et al.
Rheumatology International, 2018
Familial Mediterranean fever gene mutations as a risk factor for early coronary artery disease.
Basar N et al.
International Journal of Rheumatic Diseases, 2017
R202Q/M694V as novel MEFV gene mutations in chronic periodontitis and familial Mediterranean fever.
Fentoğlu Ö et al.
Journal of Periodontal Research, 2017
Increased Frequency of MEFV Genes in Patients with Epigastric Pain Syndrome.
Bd C et al.
Balkan Journal of Medical Genetics : Bjmg, 2017
Image analysis of neutrophil nuclear morphology: Learning about phenotypic range and its reliable analysis from patients with pelger-Huët-anomaly and treated with colchicine.
Schnipper N et al.
Cytometry. Part B, Clinical Cytometry, 2017
Is There a Long-Term Risk for Donors With Heterozygous MEFV Mutation After Kidney Donation?
Karakose S et al.
Transplantation Proceedings, 2017
The association between MEFV gene polymorphisms and Henoch-Schönlein purpura, and additional SNP-SNP interactions in Chinese Han children.
Xiong S et al.
Rheumatology International, 2017
Evaluation of subclinical inflammation in familial Mediterranean fever patients: relations with mutation types and attack status: a retrospective study.
Kelesoglu FM et al.
Clinical Rheumatology, 2016
Familial Mediterranean fever presenting as fever of unknown origin in Korea.
Lee JH et al.
Korean Journal of Pediatrics, 2016
[A Case of FMF (Familial Mediterranean Fever) with HLA-B*39 and HLA-B*40 as Disease-promoting Factors].
Tokunaga T et al.
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine, 2016
Prevalence of Fabry Disease in Familial Mediterranean Fever Patients from Central Anatolia of Turkey.
Huzmeli C et al.
Biochemical Genetics, 2016
Could familial Mediterranean fever gene mutations be related to PFAPA syndrome?
Celiksoy MH et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology, 2016
Prevalence and significance of MEFV gene mutations in patients with sarcoidosis.
Sever F et al.
Scandinavian Journal of Rheumatology, 2016
Relationship between clinical findings and genetic mutations in patients with familial Mediterranean fever.
Kilic A et al.
Pediatric Rheumatology Online Journal, 2015
Familial Mediterranean fever gene (MEFV) mutations and disease severity in systemic lupus erythematosus (SLE): implications for the role of the E148Q MEFV allele in inflammation.
Deniz R et al.
Lupus, 2015
High frequency of E148Q sequence variation in children with familial Mediterranean fever in southeast Turkey.
Uluca Ü et al.
Archivos Argentinos De Pediatria, 2015
Increased prevalence of MEFV exon 10 variants in Japanese patients with adult-onset Still's disease.
Nonaka F et al.
Clinical and Experimental Immunology, 2015
MEFV mutations in Egyptian children with systemic-onset juvenile idiopathic arthritis.
Lotfy HM et al.
Molecular Diagnosis & Therapy, 2014